NASDAQ
GenSight Biologics S.A. (GSGTF) has a current ratio of 0.39x as of Monday, May 25, 2026. This represents a 64.74% decrease compared to its 12-month average of 1.12x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.